All stories tagged :

People

ECD Automotive Design Announces 1-for-40 Reverse Stock Split

admin
People

Chronic Pain Centre of Excellence for Canadian Veterans and Bayshore HealthCare...

admin
People

Top Vancouver Catering Company, Seasons Catering, Releases The Valentine’s Seasonal Menu...

admin
People

Agreement Between L’Oréal and Sanofi for the Repurchase by Sanofi of...

admin
People

ODDITY Announces New $200 Million Credit Facility

admin
People

Focus ADHD Launches Virtual ADHD Clinic for Florida Professionals, Now Serving...

admin
People

Foundation Cream Growth Opportunities and Market Strategies, 2025-2030: Increased Adoption of...

admin
People

Body Augmentation Fillers Market Analysis Report 2024: Global Market to Surpass...

admin
People

Professional Teeth Whitening Market Outlook Report 2025-2030: Subscription-Based Whitening Services are...

admin
People

Global Dermocosmetics Market Projected to Surge to $112.51 Billion by 2034,...

admin
People

Procurement Software Market Valuation is Poised to Surpass US$ 17.87 Billion...

admin

Featured

Pr Newswire

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

admin
Pr Newswire

Virtual IT Group and The Instillery Go to Town on Zero...

admin
Pr Newswire

HKUST Deepens Sweden Ties Positioning Hong Kong as a Strategic Nexus...

admin
Pr Newswire

Monopar to Present New Long-Term Neurological Efficacy and Safety Data for...

admin
admin

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

7 new NEFECON® real-world evidence abstracts will be presented at the 18th International lgA Nephropathy Symposium (IIgANN 2025). The newly released results, based on clinical practices at several leading hospitals in China, offer a comprehensive overview of the efficacy and safety of NEFECON® in the treatment of IgA...